ASM International NV (ASM) is a supplier of wafer processing equipment for semiconductor manufacturing. It manufactures and sells equipment used in wafer processing, encompassing the fabrication steps in which silicon wafers are layered with semiconductor devices. The company offers ALD, EPI, silicon carbide epitaxy, pecvd and vertical furnaces, and spare parts.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

ASM's R&D focuses on producing innovative products that meet customers’ expectations. Its R&D activities focus on common needs for advanced process and materials development and process integration work for the advanced nodes. Its innovation strategy focuses on a three-pronged innovation model, including basic materials and process R&D, process integration testing, and product development. The company’s product-development sites are centers of excellence for a subset of products and technology. It operates eight R&D facilities in Belgium, Finland, Italy, Japan, the Netherlands, South Korea, and the US. The company’s product development site in Almere, the Netherlands focuses on vertical furnaces; Phoenix site in the US focuses on Epi and thermal atomic layer deposition (ALD), whereas its Dongtan site in South Korea focuses on plasma-enhanced atomic layer deposition (PEALD), and Tama site in Japan focuses on plasma-enhanced chemical vapor deposition (PECVD) and PEALD, in collaboration with Dongtan. ASM's R&D portfolio, technology, and product roadmaps are aligned with its customers mutually defined controlled process. As of December 2022, the company had a portfolio of over 2,619 patents. It had 965 employees in its R&D. In FY2022, the company incurred expenses of EUR233.9 million on R&D, which as a percentage of revenue, stood at 9.7%.